Annual Current Assets
$1.90 M
-$1.21 M-38.86%
31 December 2023
Summary:
Brainstorm Cell Therapeutics annual total current assets is currently $1.90 million, with the most recent change of -$1.21 million (-38.86%) on 31 December 2023. During the last 3 years, it has fallen by -$41.34 million (-95.61%). BCLI annual current assets is now -95.61% below its all-time high of $43.24 million, reached on 31 December 2020.BCLI Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$364.00 K
-$3.45 M-90.46%
30 September 2024
Summary:
Brainstorm Cell Therapeutics quarterly total current assets is currently $364.00 thousand, with the most recent change of -$3.45 million (-90.46%) on 30 September 2024. Over the past year, it has dropped by -$1.18 million (-76.35%). BCLI quarterly current assets is now -99.16% below its all-time high of $43.24 million, reached on 31 December 2020.BCLI Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCLI Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.9% | -76.3% |
| 3 y3 years | -95.6% | -98.7% |
| 5 y5 years | -81.5% | -92.2% |
BCLI Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -95.6% | at low | -98.7% | at low |
| 5 y | 5 years | -95.6% | at low | -99.2% | at low |
| alltime | all time | -95.6% | -99.2% |
Brainstorm Cell Therapeutics Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $364.00 K(-90.5%) |
| June 2024 | - | $3.82 M(+203.1%) |
| Mar 2024 | - | $1.26 M(-33.7%) |
| Dec 2023 | $2.31 M(-56.8%) | $1.90 M(+23.4%) |
| Sept 2023 | - | $1.54 M(+26.9%) |
| June 2023 | - | $1.21 M(-58.6%) |
| Mar 2023 | - | $2.93 M(-5.7%) |
| Dec 2022 | $5.34 M(-10.9%) | $3.11 M(-58.6%) |
| Sept 2022 | - | $7.50 M(-41.4%) |
| June 2022 | - | $12.81 M(-33.5%) |
| Mar 2022 | - | $19.26 M(-17.3%) |
| Dec 2021 | $6.00 M(-25.2%) | $23.28 M(-16.7%) |
| Sept 2021 | - | $27.94 M(-20.6%) |
| June 2021 | - | $35.19 M(-14.2%) |
| Mar 2021 | - | $41.03 M(-5.1%) |
| Dec 2020 | $8.02 M(+152.6%) | $43.24 M(+42.5%) |
| Sept 2020 | - | $30.34 M(+82.4%) |
| June 2020 | - | $16.63 M(+9.4%) |
| Mar 2020 | - | $15.21 M(+352.5%) |
| Dec 2019 | $3.17 M(+231.3%) | $3.36 M(-28.1%) |
| Sept 2019 | - | $4.67 M(-15.6%) |
| June 2019 | - | $5.54 M(-33.0%) |
| Mar 2019 | - | $8.26 M(-19.6%) |
| Dec 2018 | $958.00 K(-46.8%) | $10.27 M(-18.6%) |
| Sept 2018 | - | $12.62 M(-35.5%) |
| June 2018 | - | $19.56 M(+148.7%) |
| Mar 2018 | - | $7.87 M(-18.3%) |
| Dec 2017 | $1.80 M(+459.0%) | $9.62 M(-12.1%) |
| Sept 2017 | - | $10.95 M(+42.6%) |
| June 2017 | - | $7.68 M(-12.0%) |
| Mar 2017 | - | $8.72 M(-16.5%) |
| Dec 2016 | $322.00 K(+10.3%) | $10.44 M(-8.3%) |
| Sept 2016 | - | $11.38 M(-11.1%) |
| June 2016 | - | $12.81 M(-5.2%) |
| Mar 2016 | - | $13.51 M(-19.5%) |
| Dec 2015 | $292.00 K(-12.3%) | $16.79 M(-7.2%) |
| Sept 2015 | - | $18.09 M(-9.8%) |
| June 2015 | - | $20.06 M(-9.1%) |
| Mar 2015 | - | $22.08 M(+130.5%) |
| Dec 2014 | $333.00 K(+18.9%) | $9.58 M(-13.8%) |
| Sept 2014 | - | $11.11 M(-9.0%) |
| June 2014 | - | $12.21 M(+216.8%) |
| Mar 2014 | - | $3.85 M(-13.3%) |
| Dec 2013 | $280.00 K | $4.45 M(-21.6%) |
| Sept 2013 | - | $5.67 M(+72.4%) |
| June 2013 | - | $3.29 M(-23.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $4.30 M(-11.8%) |
| Dec 2012 | $264.00 K(-40.0%) | $4.87 M(-7.8%) |
| Sept 2012 | - | $5.29 M(+277.2%) |
| June 2012 | - | $1.40 M(-21.1%) |
| Mar 2012 | - | $1.77 M(-23.0%) |
| Dec 2011 | $440.00 K(-13.7%) | $2.30 M(-17.6%) |
| Sept 2011 | - | $2.80 M(-10.8%) |
| June 2011 | - | $3.13 M(-19.3%) |
| Mar 2011 | - | $3.88 M(+571.0%) |
| Dec 2010 | $510.00 K(-23.9%) | $579.00 K(-33.4%) |
| Sept 2010 | - | $869.00 K(-6.3%) |
| June 2010 | - | $927.00 K(-32.5%) |
| Mar 2010 | - | $1.37 M(+1478.2%) |
| Dec 2009 | $670.00 K(-17.9%) | $87.00 K(-8.4%) |
| Sept 2009 | - | $95.00 K(+6.7%) |
| June 2009 | - | $89.00 K(+15.6%) |
| Mar 2009 | - | $77.00 K(+30.5%) |
| Dec 2008 | $816.00 K(-1.1%) | $59.00 K(-60.1%) |
| Sept 2008 | - | $148.00 K(-10.3%) |
| June 2008 | - | $165.00 K(+58.7%) |
| Mar 2008 | - | $104.00 K(-59.7%) |
| Dec 2007 | $825.00 K(+40.1%) | $258.00 K(-26.3%) |
| Sept 2007 | - | $350.00 K(+184.6%) |
| June 2007 | - | $123.00 K(+26.2%) |
| Mar 2007 | - | $97.50 K(-33.7%) |
| Dec 2006 | $589.00 K(+18.9%) | - |
| Sept 2006 | - | $147.00 K(-61.6%) |
| June 2006 | - | $382.80 K(+5.0%) |
| Mar 2006 | - | $364.60 K(+152.3%) |
| Mar 2006 | $495.20 K(+111.4%) | - |
| Dec 2005 | - | $144.50 K(-61.7%) |
| Sept 2005 | - | $377.70 K(-16.3%) |
| June 2005 | - | $451.50 K(-30.0%) |
| Mar 2005 | $234.20 K(+1345.7%) | $645.20 K(+110.5%) |
| Dec 2004 | - | $306.50 K(+461.4%) |
| Sept 2004 | - | $54.60 K(-19.7%) |
| June 2004 | - | $68.00 K(>+9900.0%) |
| Mar 2004 | $16.20 K(-54.0%) | $0.00(-100.0%) |
| Dec 2003 | - | $4700.00(-28.8%) |
| Sept 2003 | - | $6600.00(-32.7%) |
| June 2003 | - | $9800.00(-4.9%) |
| Mar 2003 | $35.20 K(+31.3%) | $10.30 K(-34.4%) |
| Dec 2002 | - | $15.70 K(-55.5%) |
| Sept 2002 | - | $35.30 K(0.0%) |
| June 2002 | - | $35.30 K |
| Mar 2002 | $26.80 K | - |
FAQ
- What is Brainstorm Cell Therapeutics annual total current assets?
- What is the all time high annual current assets for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics annual current assets year-on-year change?
- What is Brainstorm Cell Therapeutics quarterly total current assets?
- What is the all time high quarterly current assets for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics quarterly current assets year-on-year change?
What is Brainstorm Cell Therapeutics annual total current assets?
The current annual current assets of BCLI is $1.90 M
What is the all time high annual current assets for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high annual total current assets is $43.24 M
What is Brainstorm Cell Therapeutics annual current assets year-on-year change?
Over the past year, BCLI annual total current assets has changed by -$1.21 M (-38.86%)
What is Brainstorm Cell Therapeutics quarterly total current assets?
The current quarterly current assets of BCLI is $364.00 K
What is the all time high quarterly current assets for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high quarterly total current assets is $43.24 M
What is Brainstorm Cell Therapeutics quarterly current assets year-on-year change?
Over the past year, BCLI quarterly total current assets has changed by -$1.18 M (-76.35%)